The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice

Cardiovascular Research

Volumn 84, Issue 3, 2009, Pages 485-493

  Grassia, Gianluca ^a   Maddaluno, Marcella ^a   Guglielmotti, Angelo ^b   Mangano, Giorgina ^b   Biondi, Giuseppe ^b   Maffia, Pasquale ^a,c   Ialenti, Armando ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Piazzale della Stazione SNC   (Italy)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Bindarit; Macrophages; Monocyte chemoattractant protein 1; Neointima hyperplasia; Vascular smooth muscle cells

Indexed keywords

ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN E; BETA ACTIN; BINDARIT; CD68 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY INJURY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELECTIVITY; ENDOTHELIUM; FEMALE; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; TREATMENT OUTCOME; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEINS E; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; FEMALE; HYPERLIPIDEMIAS; INDAZOLES; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; PROPIONIC ACIDS; RATS; RATS, WISTAR;

EID: 70849097192     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp238     Document Type: Article

References (33)

1. Zoja C, Corna G, Morigi M, Donarelli R, Guglielmotti A, Pinza M et al. Bin-darit retards renal disease and prolongs survival in murine lupus autoimmune disease. Kidney Int 1998;53:726-734.
2. Guglielmotti A, D'Onofrio E, Coletta I, Aquilini L, Milanese C, Pinza M. Amelioration of rat adjuvant arthritis by therapeutic treatment with bin-darit, an inhibitor of MCP-1 and TNF-a production. Inflamm Res 2002;51: 252-258.
3. Bhatia M, Devi Ramnath RD, Chevali L, Guglielmotti A. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2005;288: G1259-G1265.
4. Bhatia M, Landolfi C, Basta F, Bovi G, Devi Ramnath RD, Capezzone de Joannon A et al. Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis. Inflamm Res 2008;57:1-8.
5. Mirolo M, Fabbri M, Sironi M, Vecchi A, Guglielmotti A, Mangano G et al. Impact of the anti-inflammatory agent on the chemokinome: selective inhibition of the monocyte chemotactic proteins. Eur Cytokine Netw 2008;19:119-122.
6. Perico N, Benigni A, Remuzzi G. Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov 2008;7:936-1853
7. The Pharmaprojects Database, Informa UK Ltd 2008. www. pharmaprojects.com (accession no. 17736).
8. Schober A. Chemokines in vascular dysfunction and remodeling. Arterios-cler Thromb Vasc Biol 2008;28:1950-1959.
9. Furukawa Y, Matsumori A, Ohashi N, Shioi T, Ono K, Harada A et al. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res 1999;84:306-314.
10. Egashira K, Koyanagi M, Kitamoto S, Ni W, Kataoka C, Moroshita R et al. Anti-monocyte chemoattractant protein-1 therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synythesis. FASEB J 2000;14:1974-1978.
11. Egashira K, Nakano K, Ohtani K, Funakoshi K, Zhao G, Ihara Yet al. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys. Arterioscler Thromb Vasc Biol 2007;27:2563-2568.
12. Nakano K, Egashira K, Ohtani K, Zhao G, Funakoshi K, Ihara Y et al. Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeys. Atherosclerosis 2007;194:309-316.
13. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001;21:327-334. (Pubitemid 32199112)
14. Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH, Banerjee A. Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol 2002;283:H1455-H1461.
15. Massberg S, Vogt F, Dickfeld T, Brand K, Page S, Gawaz M. Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells. Thromb Res 2003;110:187-194.
16. Parenti A, Bellik L, Brogelli L, Filippi S, Ledda F. Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2004;286:H1978-H1984.
17. Schepers A, Eefting D, Bonta PI, Grimbergen JM, de Vries MR, van Weel V et al. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler Thromb Vasc Biol 2006;26:2063-2069.
18. Maffia P, Grassia G, Di Meglio P, Carnuccio R, Berrino L, Garside P et al. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Circulation 2006;114:430-437.
19. Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury. Circ Res 1993;73:792-796.
20. Asahara T, Chen D, Tsurumi Y, Kearney M, Rossow S, Passeri J et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 1996;94:3291-3302.
21. Yue TL, Vickery-Clark L, Louden CS, Gu JL, Ma XL, Narayanan PK et al. Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury. Circulation 2000;102: III281-III288.
22. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801.
23. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res 2004;95:858-866.
24. Martinovic I, Abegunewardene N, Seul M, Vosseler M, Horstick G, Buerke M et al. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J 2005;69: 1484-1489.
25. Reidy MA, Fingerle J, Lindner V. Factors controlling the development of arterial lesions after injury. Circulation 1992;86:III-43-III-46.
26. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol 2000;20:335-342.
27. Yu X, Dluz S, Graves DT, Zhang L, Antoniades HN, Hollander W et al. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 1992;89:6953-6957.
28. Han KH, Tangirala RK, Green SR, Quehenberger O. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. Arterioscl Thromb Vasc Biol 1998;18: 1983-1991.
29. Oguchi S, Dimayuga P, Zhu J, Chyu KY, Yano J, Shah PK et al. Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscl Thromb Vasc Biol 2000;20: 1729-1736.
30. Galkina E, Kadl A, Sanders J, Varughese D, Sarembock IJ, Ley K. Lynpho-cyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 2006;203: 1273-1282.
31. Maffia P, Zinselmeyer BH, Ialenti A, Kennedy S, Baker A, McInnes IB et al. Multiphoton microscopy for 3-dimensional imaging of lymphocyte recruitment into apolipoprotein-E-deficient mouse carotid artery. Circulation 2007;115:e326-e328.
32. Mori E, Komori K, Yamaoka T, Tanii M, Kataoka C, Takeshita A et al. Essential role of monocyte chemoattractant protein-1 in development of rest-enotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits. Circulation 2002;105:2905-2910.
33. Schober A, Zernecke A, Liehn EA, von Hundelshausen P, Knarren S, Kuziel WA et al. Crucial role of the CCL2/CCR2 axis in neointimal hyper-plasia after arterial injury in hyperlipidemic mice involves early mono-cyte recruitment and CCL2 presentation on platelets. Circ Res 2004;95: 1125-1133.